Format

Send to

Choose Destination
Macromol Biosci. 2017 Oct;17(10). doi: 10.1002/mabi.201700029. Epub 2017 Apr 5.

Design of Poly-l-Glutamate-Based Complexes for pDNA Delivery.

Author information

1
Polymer Therapeutics Lab, Centro de Investigación Príncipe Felipe (CIPF), C/Eduardo Primo Yúfera 3, Valencia, 46012, Spain.
2
Pharmaceutical Biotechnology, Department of Pharmacy, Center for Nanoscience, Ludwig-Maximilians-Universität, Butenandtstr. 5-13, Building D, 81377, Munich, Germany.

Abstract

Due to the polyanionic nature of DNA, typically cationic or neutral delivery vehicles have been used for gene delivery. As a new approach, this study focuses on the design, development, and validation of nonviral polypeptide-based carriers for oligonucleotide delivery based on a negatively charged poly-l-glutamic acid (PGA) backbone partly derivatized with oligoaminoamide residues. To this end, PGA-derivatives modified with different pentameric succinyl tetraethylene pentamines (Stp5 ) are designed. Optionally, histidines for modulation of endosomal buffer capacity and cysteines for pDNA complex stabilization are included, followed by characterization of biophysical properties and gene transfer efficiency in N2a neuroblastoma or 4T1 breast cancer cells.

KEYWORDS:

pDNA delivery; polyglutamates; polymer therapeutics; polyplex

PMID:
28378951
DOI:
10.1002/mabi.201700029
[Indexed for MEDLINE]

Supplemental Content

Full text links

Icon for Wiley
Loading ...
Support Center